ABHD12 Back

abhydrolase domain containing 12

External References:      Wikipedia GeneCards HUGO COSMIC Google Scholar

NCBI Description of ABHD12
This gene encodes an enzyme that catalyzes the hydrolysis of 2-arachidonoyl glycerol (2-AG), the main endocannabinoid lipid transmitter that acts on cannabinoid receptors, CB1 and CB2. The endocannabinoid system is involved in a wide range of physiological processes, including neurotransmission, mood, appetite, pain appreciation, addiction behavior, and inflammation. Mutations in this gene are associated with the neurodegenerative disease, PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract), resulting from an inborn error of endocannabinoid metabolism. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene.

Community Annotation of ABHD12 Add / Edit ABHD12: Annotations

No community annotations yet for ABHD12.
Sort mutations by: Tumor type  Mutation type  Position  
Straightedge cursor Expand

Figure notes


• "Mouse over" a mutation to see details.
• Missense green saturation indicates evolutionary conservation of the mutated positions.
• Red hashes in protein strip are splice sites.
• Blue-white-red bars are log2 copy ratio distributions (–1 to +1) from Zack et al. (2013).


Legend

ABHD12 is highly significantly mutated in
(none)
ABHD12 is significantly mutated in
(none)
ABHD12 is near significance in
(none)

Click on a tumor type to see its full list of significant genes.

Data details


• Mutation list for ABHD12